カテゴリ： GlobalInfoResearch, 世界, 部品/材料

世界のカルバマゼピンAPI市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Carbamazepine API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO2419）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO2419
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：化学＆材料
■ ページ数：117
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のカルバマゼピンAPI市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

カルバマゼピンAPI市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のカルバマゼピンAPIの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

カルバマゼピンAPI市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・純度98%以上、純度98%、純度98%以下

用途別セグメントは次のように区分されます。
・錠剤、カプセル

世界のカルバマゼピンAPI市場の主要な市場プレーヤーは以下のとおりです。
・Novartis AG、Polpharma SA、CTX Life Sciences、Amoli Organics、Jubilant Generics、FIS-Fabbrica Italiana Sintetici SpA、Taro Pharmaceutical Industries、Siegfried AG、Dasami Lab、Teva Pharmaceutical Industries、Arevipharma、Zhejiang Jiuzhou Pharmaceutical、Shanghai Xiandai Hasen (Shangqiu) Pharmaceutical、Jiangsu Cixing Pharmaceutical、Jiangsu Tohope Pharmaceutical、Beijing Taiyang Pharmaceutical、Jiangsu Sihuan Bioengineering、Changzhou Yabang Pharmaceutical、Jinan Jinda Pharmaceutical Chemistry

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、カルバマゼピンAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なカルバマゼピンAPIメーカーの企業概要、2019年～2022年までのカルバマゼピンAPIの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なカルバマゼピンAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別カルバマゼピンAPIの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのカルバマゼピンAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのカルバマゼピンAPI市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびカルバマゼピンAPIの産業チェーンを掲載しています。
・第13、14、15章では、カルバマゼピンAPIの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- カルバマゼピンAPIの概要
- 種類別分析（2017年vs2021年vs2028年）：純度98%以上、純度98%、純度98%以下
- 用途別分析（2017年vs2021年vs2028年）：錠剤、カプセル
- 世界のカルバマゼピンAPI市場規模・予測
- 世界のカルバマゼピンAPI生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Novartis AG、Polpharma SA、CTX Life Sciences、Amoli Organics、Jubilant Generics、FIS-Fabbrica Italiana Sintetici SpA、Taro Pharmaceutical Industries、Siegfried AG、Dasami Lab、Teva Pharmaceutical Industries、Arevipharma、Zhejiang Jiuzhou Pharmaceutical、Shanghai Xiandai Hasen (Shangqiu) Pharmaceutical、Jiangsu Cixing Pharmaceutical、Jiangsu Tohope Pharmaceutical、Beijing Taiyang Pharmaceutical、Jiangsu Sihuan Bioengineering、Changzhou Yabang Pharmaceutical、Jinan Jinda Pharmaceutical Chemistry
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：純度98%以上、純度98%、純度98%以下
・用途別分析2017年-2028年：錠剤、カプセル
・カルバマゼピンAPIの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・カルバマゼピンAPIのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・カルバマゼピンAPIのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・カルバマゼピンAPIの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・カルバマゼピンAPIの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Carbamazepine API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Carbamazepine API market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Tablets accounting for % of the Carbamazepine API global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Purity Above 98% segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Carbamazepine API include Novartis AG, Polpharma SA, CTX Life Sciences, Amoli Organics, and Jubilant Generics, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Carbamazepine API market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Purity Above 98%
Purity 98%
Purity Below 98%
Market segment by Application can be divided into
Tablets
Capsules
The key market players for global Carbamazepine API market are listed below:
Novartis AG
Polpharma SA
CTX Life Sciences
Amoli Organics
Jubilant Generics
FIS-Fabbrica Italiana Sintetici SpA
Taro Pharmaceutical Industries
Siegfried AG
Dasami Lab
Teva Pharmaceutical Industries
Arevipharma
Zhejiang Jiuzhou Pharmaceutical
Shanghai Xiandai Hasen (Shangqiu) Pharmaceutical
Jiangsu Cixing Pharmaceutical
Jiangsu Tohope Pharmaceutical
Beijing Taiyang Pharmaceutical
Jiangsu Sihuan Bioengineering
Changzhou Yabang Pharmaceutical
Jinan Jinda Pharmaceutical Chemistry
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Carbamazepine API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Carbamazepine API, with price, sales, revenue and global market share of Carbamazepine API from 2019 to 2022.
Chapter 3, the Carbamazepine API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Carbamazepine API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Carbamazepine API market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Carbamazepine API.
Chapter 13, 14, and 15, to describe Carbamazepine API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Carbamazepine API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Carbamazepine API Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Purity Above 98%
1.2.3 Purity 98%
1.2.4 Purity Below 98%
1.3 Market Analysis by Application
1.3.1 Overview: Global Carbamazepine API Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Tablets
1.3.3 Capsules
1.4 Global Carbamazepine API Market Size & Forecast
1.4.1 Global Carbamazepine API Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Carbamazepine API Sales in Volume (2017-2028)
1.4.3 Global Carbamazepine API Price (2017-2028)
1.5 Global Carbamazepine API Production Capacity Analysis
1.5.1 Global Carbamazepine API Total Production Capacity (2017-2028)
1.5.2 Global Carbamazepine API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Carbamazepine API Market Drivers
1.6.2 Carbamazepine API Market Restraints
1.6.3 Carbamazepine API Trends Analysis
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business
2.1.3 Novartis AG Carbamazepine API Product and Services
2.1.4 Novartis AG Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Polpharma SA
2.2.1 Polpharma SA Details
2.2.2 Polpharma SA Major Business
2.2.3 Polpharma SA Carbamazepine API Product and Services
2.2.4 Polpharma SA Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 CTX Life Sciences
2.3.1 CTX Life Sciences Details
2.3.2 CTX Life Sciences Major Business
2.3.3 CTX Life Sciences Carbamazepine API Product and Services
2.3.4 CTX Life Sciences Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Amoli Organics
2.4.1 Amoli Organics Details
2.4.2 Amoli Organics Major Business
2.4.3 Amoli Organics Carbamazepine API Product and Services
2.4.4 Amoli Organics Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Jubilant Generics
2.5.1 Jubilant Generics Details
2.5.2 Jubilant Generics Major Business
2.5.3 Jubilant Generics Carbamazepine API Product and Services
2.5.4 Jubilant Generics Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 FIS-Fabbrica Italiana Sintetici SpA
2.6.1 FIS-Fabbrica Italiana Sintetici SpA Details
2.6.2 FIS-Fabbrica Italiana Sintetici SpA Major Business
2.6.3 FIS-Fabbrica Italiana Sintetici SpA Carbamazepine API Product and Services
2.6.4 FIS-Fabbrica Italiana Sintetici SpA Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Taro Pharmaceutical Industries
2.7.1 Taro Pharmaceutical Industries Details
2.7.2 Taro Pharmaceutical Industries Major Business
2.7.3 Taro Pharmaceutical Industries Carbamazepine API Product and Services
2.7.4 Taro Pharmaceutical Industries Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Siegfried AG
2.8.1 Siegfried AG Details
2.8.2 Siegfried AG Major Business
2.8.3 Siegfried AG Carbamazepine API Product and Services
2.8.4 Siegfried AG Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Dasami Lab
2.9.1 Dasami Lab Details
2.9.2 Dasami Lab Major Business
2.9.3 Dasami Lab Carbamazepine API Product and Services
2.9.4 Dasami Lab Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business
2.10.3 Teva Pharmaceutical Industries Carbamazepine API Product and Services
2.10.4 Teva Pharmaceutical Industries Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Arevipharma
2.11.1 Arevipharma Details
2.11.2 Arevipharma Major Business
2.11.3 Arevipharma Carbamazepine API Product and Services
2.11.4 Arevipharma Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Zhejiang Jiuzhou Pharmaceutical
2.12.1 Zhejiang Jiuzhou Pharmaceutical Details
2.12.2 Zhejiang Jiuzhou Pharmaceutical Major Business
2.12.3 Zhejiang Jiuzhou Pharmaceutical Carbamazepine API Product and Services
2.12.4 Zhejiang Jiuzhou Pharmaceutical Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Shanghai Xiandai Hasen (Shangqiu) Pharmaceutical
2.13.1 Shanghai Xiandai Hasen (Shangqiu) Pharmaceutical Details
2.13.2 Shanghai Xiandai Hasen (Shangqiu) Pharmaceutical Major Business
2.13.3 Shanghai Xiandai Hasen (Shangqiu) Pharmaceutical Carbamazepine API Product and Services
2.13.4 Shanghai Xiandai Hasen (Shangqiu) Pharmaceutical Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Jiangsu Cixing Pharmaceutical
2.14.1 Jiangsu Cixing Pharmaceutical Details
2.14.2 Jiangsu Cixing Pharmaceutical Major Business
2.14.3 Jiangsu Cixing Pharmaceutical Carbamazepine API Product and Services
2.14.4 Jiangsu Cixing Pharmaceutical Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Jiangsu Tohope Pharmaceutical
2.15.1 Jiangsu Tohope Pharmaceutical Details
2.15.2 Jiangsu Tohope Pharmaceutical Major Business
2.15.3 Jiangsu Tohope Pharmaceutical Carbamazepine API Product and Services
2.15.4 Jiangsu Tohope Pharmaceutical Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Beijing Taiyang Pharmaceutical
2.16.1 Beijing Taiyang Pharmaceutical Details
2.16.2 Beijing Taiyang Pharmaceutical Major Business
2.16.3 Beijing Taiyang Pharmaceutical Carbamazepine API Product and Services
2.16.4 Beijing Taiyang Pharmaceutical Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17 Jiangsu Sihuan Bioengineering
2.17.1 Jiangsu Sihuan Bioengineering Details
2.17.2 Jiangsu Sihuan Bioengineering Major Business
2.17.3 Jiangsu Sihuan Bioengineering Carbamazepine API Product and Services
2.17.4 Jiangsu Sihuan Bioengineering Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18 Changzhou Yabang Pharmaceutical
2.18.1 Changzhou Yabang Pharmaceutical Details
2.18.2 Changzhou Yabang Pharmaceutical Major Business
2.18.3 Changzhou Yabang Pharmaceutical Carbamazepine API Product and Services
2.18.4 Changzhou Yabang Pharmaceutical Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19 Jinan Jinda Pharmaceutical Chemistry
2.19.1 Jinan Jinda Pharmaceutical Chemistry Details
2.19.2 Jinan Jinda Pharmaceutical Chemistry Major Business
2.19.3 Jinan Jinda Pharmaceutical Chemistry Carbamazepine API Product and Services
2.19.4 Jinan Jinda Pharmaceutical Chemistry Carbamazepine API Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Carbamazepine API Breakdown Data by Manufacturer
3.1 Global Carbamazepine API Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Carbamazepine API Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Carbamazepine API
3.4 Market Concentration Rate
3.4.1 Top 3 Carbamazepine API Manufacturer Market Share in 2021
3.4.2 Top 6 Carbamazepine API Manufacturer Market Share in 2021
3.5 Global Carbamazepine API Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Carbamazepine API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Carbamazepine API Market Size by Region
4.1.1 Global Carbamazepine API Sales in Volume by Region (2017-2028)
4.1.2 Global Carbamazepine API Revenue by Region (2017-2028)
4.2 North America Carbamazepine API Revenue (2017-2028)
4.3 Europe Carbamazepine API Revenue (2017-2028)
4.4 Asia-Pacific Carbamazepine API Revenue (2017-2028)
4.5 South America Carbamazepine API Revenue (2017-2028)
4.6 Middle East and Africa Carbamazepine API Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Carbamazepine API Sales in Volume by Type (2017-2028)
5.2 Global Carbamazepine API Revenue by Type (2017-2028)
5.3 Global Carbamazepine API Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Carbamazepine API Sales in Volume by Application (2017-2028)
6.2 Global Carbamazepine API Revenue by Application (2017-2028)
6.3 Global Carbamazepine API Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Carbamazepine API Sales by Type (2017-2028)
7.2 North America Carbamazepine API Sales by Application (2017-2028)
7.3 North America Carbamazepine API Market Size by Country
7.3.1 North America Carbamazepine API Sales in Volume by Country (2017-2028)
7.3.2 North America Carbamazepine API Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Carbamazepine API Sales by Type (2017-2028)
8.2 Europe Carbamazepine API Sales by Application (2017-2028)
8.3 Europe Carbamazepine API Market Size by Country
8.3.1 Europe Carbamazepine API Sales in Volume by Country (2017-2028)
8.3.2 Europe Carbamazepine API Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Carbamazepine API Sales by Type (2017-2028)
9.2 Asia-Pacific Carbamazepine API Sales by Application (2017-2028)
9.3 Asia-Pacific Carbamazepine API Market Size by Region
9.3.1 Asia-Pacific Carbamazepine API Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Carbamazepine API Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Carbamazepine API Sales by Type (2017-2028)
10.2 South America Carbamazepine API Sales by Application (2017-2028)
10.3 South America Carbamazepine API Market Size by Country
10.3.1 South America Carbamazepine API Sales in Volume by Country (2017-2028)
10.3.2 South America Carbamazepine API Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Carbamazepine API Sales by Type (2017-2028)
11.2 Middle East & Africa Carbamazepine API Sales by Application (2017-2028)
11.3 Middle East & Africa Carbamazepine API Market Size by Country
11.3.1 Middle East & Africa Carbamazepine API Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Carbamazepine API Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Carbamazepine API and Key Manufacturers
12.2 Manufacturing Costs Percentage of Carbamazepine API
12.3 Carbamazepine API Production Process
12.4 Carbamazepine API Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Carbamazepine API Typical Distributors
13.3 Carbamazepine API Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Carbamazepine API Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Carbamazepine API Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 4. Novartis AG Major Business
Table 5. Novartis AG Carbamazepine API Product and Services
Table 6. Novartis AG Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Polpharma SA Basic Information, Manufacturing Base and Competitors
Table 8. Polpharma SA Major Business
Table 9. Polpharma SA Carbamazepine API Product and Services
Table 10. Polpharma SA Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. CTX Life Sciences Basic Information, Manufacturing Base and Competitors
Table 12. CTX Life Sciences Major Business
Table 13. CTX Life Sciences Carbamazepine API Product and Services
Table 14. CTX Life Sciences Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Amoli Organics Basic Information, Manufacturing Base and Competitors
Table 16. Amoli Organics Major Business
Table 17. Amoli Organics Carbamazepine API Product and Services
Table 18. Amoli Organics Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Jubilant Generics Basic Information, Manufacturing Base and Competitors
Table 20. Jubilant Generics Major Business
Table 21. Jubilant Generics Carbamazepine API Product and Services
Table 22. Jubilant Generics Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. FIS-Fabbrica Italiana Sintetici SpA Basic Information, Manufacturing Base and Competitors
Table 24. FIS-Fabbrica Italiana Sintetici SpA Major Business
Table 25. FIS-Fabbrica Italiana Sintetici SpA Carbamazepine API Product and Services
Table 26. FIS-Fabbrica Italiana Sintetici SpA Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Taro Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 28. Taro Pharmaceutical Industries Major Business
Table 29. Taro Pharmaceutical Industries Carbamazepine API Product and Services
Table 30. Taro Pharmaceutical Industries Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Siegfried AG Basic Information, Manufacturing Base and Competitors
Table 32. Siegfried AG Major Business
Table 33. Siegfried AG Carbamazepine API Product and Services
Table 34. Siegfried AG Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Dasami Lab Basic Information, Manufacturing Base and Competitors
Table 36. Dasami Lab Major Business
Table 37. Dasami Lab Carbamazepine API Product and Services
Table 38. Dasami Lab Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 40. Teva Pharmaceutical Industries Major Business
Table 41. Teva Pharmaceutical Industries Carbamazepine API Product and Services
Table 42. Teva Pharmaceutical Industries Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Arevipharma Basic Information, Manufacturing Base and Competitors
Table 44. Arevipharma Major Business
Table 45. Arevipharma Carbamazepine API Product and Services
Table 46. Arevipharma Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Zhejiang Jiuzhou Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Zhejiang Jiuzhou Pharmaceutical Major Business
Table 49. Zhejiang Jiuzhou Pharmaceutical Carbamazepine API Product and Services
Table 50. Zhejiang Jiuzhou Pharmaceutical Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Shanghai Xiandai Hasen (Shangqiu) Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 52. Shanghai Xiandai Hasen (Shangqiu) Pharmaceutical Major Business
Table 53. Shanghai Xiandai Hasen (Shangqiu) Pharmaceutical Carbamazepine API Product and Services
Table 54. Shanghai Xiandai Hasen (Shangqiu) Pharmaceutical Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Jiangsu Cixing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 56. Jiangsu Cixing Pharmaceutical Major Business
Table 57. Jiangsu Cixing Pharmaceutical Carbamazepine API Product and Services
Table 58. Jiangsu Cixing Pharmaceutical Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Jiangsu Tohope Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 60. Jiangsu Tohope Pharmaceutical Major Business
Table 61. Jiangsu Tohope Pharmaceutical Carbamazepine API Product and Services
Table 62. Jiangsu Tohope Pharmaceutical Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Beijing Taiyang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 64. Beijing Taiyang Pharmaceutical Major Business
Table 65. Beijing Taiyang Pharmaceutical Carbamazepine API Product and Services
Table 66. Beijing Taiyang Pharmaceutical Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Jiangsu Sihuan Bioengineering Basic Information, Manufacturing Base and Competitors
Table 68. Jiangsu Sihuan Bioengineering Major Business
Table 69. Jiangsu Sihuan Bioengineering Carbamazepine API Product and Services
Table 70. Jiangsu Sihuan Bioengineering Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 71. Changzhou Yabang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 72. Changzhou Yabang Pharmaceutical Major Business
Table 73. Changzhou Yabang Pharmaceutical Carbamazepine API Product and Services
Table 74. Changzhou Yabang Pharmaceutical Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 75. Jinan Jinda Pharmaceutical Chemistry Basic Information, Manufacturing Base and Competitors
Table 76. Jinan Jinda Pharmaceutical Chemistry Major Business
Table 77. Jinan Jinda Pharmaceutical Chemistry Carbamazepine API Product and Services
Table 78. Jinan Jinda Pharmaceutical Chemistry Carbamazepine API Sales (Tons), Price (US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 79. Global Carbamazepine API Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)
Table 80. Global Carbamazepine API Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 81. Market Position of Manufacturers in Carbamazepine API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 82. Global Carbamazepine API Production Capacity by Company, (Tons): 2020 VS 2021
Table 83. Head Office and Carbamazepine API Production Site of Key Manufacturer
Table 84. Carbamazepine API New Entrant and Capacity Expansion Plans
Table 85. Carbamazepine API Mergers & Acquisitions in the Past Five Years
Table 86. Global Carbamazepine API Sales by Region (2017-2022) & (Tons)
Table 87. Global Carbamazepine API Sales by Region (2023-2028) & (Tons)
Table 88. Global Carbamazepine API Revenue by Region (2017-2022) & (USD Million)
Table 89. Global Carbamazepine API Revenue by Region (2023-2028) & (USD Million)
Table 90. Global Carbamazepine API Sales by Type (2017-2022) & (Tons)
Table 91. Global Carbamazepine API Sales by Type (2023-2028) & (Tons)
Table 92. Global Carbamazepine API Revenue by Type (2017-2022) & (USD Million)
Table 93. Global Carbamazepine API Revenue by Type (2023-2028) & (USD Million)
Table 94. Global Carbamazepine API Price by Type (2017-2022) & (US$/Kg)
Table 95. Global Carbamazepine API Price by Type (2023-2028) & (US$/Kg)
Table 96. Global Carbamazepine API Sales by Application (2017-2022) & (Tons)
Table 97. Global Carbamazepine API Sales by Application (2023-2028) & (Tons)
Table 98. Global Carbamazepine API Revenue by Application (2017-2022) & (USD Million)
Table 99. Global Carbamazepine API Revenue by Application (2023-2028) & (USD Million)
Table 100. Global Carbamazepine API Price by Application (2017-2022) & (US$/Kg)
Table 101. Global Carbamazepine API Price by Application (2023-2028) & (US$/Kg)
Table 102. North America Carbamazepine API Sales by Country (2017-2022) & (Tons)
Table 103. North America Carbamazepine API Sales by Country (2023-2028) & (Tons)
Table 104. North America Carbamazepine API Revenue by Country (2017-2022) & (USD Million)
Table 105. North America Carbamazepine API Revenue by Country (2023-2028) & (USD Million)
Table 106. North America Carbamazepine API Sales by Type (2017-2022) & (Tons)
Table 107. North America Carbamazepine API Sales by Type (2023-2028) & (Tons)
Table 108. North America Carbamazepine API Sales by Application (2017-2022) & (Tons)
Table 109. North America Carbamazepine API Sales by Application (2023-2028) & (Tons)
Table 110. Europe Carbamazepine API Sales by Country (2017-2022) & (Tons)
Table 111. Europe Carbamazepine API Sales by Country (2023-2028) & (Tons)
Table 112. Europe Carbamazepine API Revenue by Country (2017-2022) & (USD Million)
Table 113. Europe Carbamazepine API Revenue by Country (2023-2028) & (USD Million)
Table 114. Europe Carbamazepine API Sales by Type (2017-2022) & (Tons)
Table 115. Europe Carbamazepine API Sales by Type (2023-2028) & (Tons)
Table 116. Europe Carbamazepine API Sales by Application (2017-2022) & (Tons)
Table 117. Europe Carbamazepine API Sales by Application (2023-2028) & (Tons)
Table 118. Asia-Pacific Carbamazepine API Sales by Region (2017-2022) & (Tons)
Table 119. Asia-Pacific Carbamazepine API Sales by Region (2023-2028) & (Tons)
Table 120. Asia-Pacific Carbamazepine API Revenue by Region (2017-2022) & (USD Million)
Table 121. Asia-Pacific Carbamazepine API Revenue by Region (2023-2028) & (USD Million)
Table 122. Asia-Pacific Carbamazepine API Sales by Type (2017-2022) & (Tons)
Table 123. Asia-Pacific Carbamazepine API Sales by Type (2023-2028) & (Tons)
Table 124. Asia-Pacific Carbamazepine API Sales by Application (2017-2022) & (Tons)
Table 125. Asia-Pacific Carbamazepine API Sales by Application (2023-2028) & (Tons)
Table 126. South America Carbamazepine API Sales by Country (2017-2022) & (Tons)
Table 127. South America Carbamazepine API Sales by Country (2023-2028) & (Tons)
Table 128. South America Carbamazepine API Revenue by Country (2017-2022) & (USD Million)
Table 129. South America Carbamazepine API Revenue by Country (2023-2028) & (USD Million)
Table 130. South America Carbamazepine API Sales by Type (2017-2022) & (Tons)
Table 131. South America Carbamazepine API Sales by Type (2023-2028) & (Tons)
Table 132. South America Carbamazepine API Sales by Application (2017-2022) & (Tons)
Table 133. South America Carbamazepine API Sales by Application (2023-2028) & (Tons)
Table 134. Middle East & Africa Carbamazepine API Sales by Region (2017-2022) & (Tons)
Table 135. Middle East & Africa Carbamazepine API Sales by Region (2023-2028) & (Tons)
Table 136. Middle East & Africa Carbamazepine API Revenue by Region (2017-2022) & (USD Million)
Table 137. Middle East & Africa Carbamazepine API Revenue by Region (2023-2028) & (USD Million)
Table 138. Middle East & Africa Carbamazepine API Sales by Type (2017-2022) & (Tons)
Table 139. Middle East & Africa Carbamazepine API Sales by Type (2023-2028) & (Tons)
Table 140. Middle East & Africa Carbamazepine API Sales by Application (2017-2022) & (Tons)
Table 141. Middle East & Africa Carbamazepine API Sales by Application (2023-2028) & (Tons)
Table 142. Carbamazepine API Raw Material
Table 143. Key Manufacturers of Carbamazepine API Raw Materials
Table 144. Direct Channel Pros & Cons
Table 145. Indirect Channel Pros & Cons
Table 146. Carbamazepine API Typical Distributors
Table 147. Carbamazepine API Typical Customers
List of Figures
Figure 1. Carbamazepine API Picture
Figure 2. Global Carbamazepine API Revenue Market Share by Type in 2021
Figure 3. Purity Above 98%
Figure 4. Purity 98%
Figure 5. Purity Below 98%
Figure 6. Global Carbamazepine API Revenue Market Share by Application in 2021
Figure 7. Tablets
Figure 8. Capsules
Figure 9. Global Carbamazepine API Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028
Figure 10. Global Carbamazepine API Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Carbamazepine API Sales (2017-2028) & (Tons)
Figure 12. Global Carbamazepine API Price (2017-2028) & (US$/Kg)
Figure 13. Global Carbamazepine API Production Capacity (2017-2028) & (Tons)
Figure 14. Global Carbamazepine API Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Carbamazepine API Market Drivers
Figure 16. Carbamazepine API Market Restraints
Figure 17. Carbamazepine API Market Trends
Figure 18. Global Carbamazepine API Sales Market Share by Manufacturer in 2021
Figure 19. Global Carbamazepine API Revenue Market Share by Manufacturer in 2021
Figure 20. Carbamazepine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Carbamazepine API Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Carbamazepine API Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Carbamazepine API Sales Market Share by Region (2017-2028)
Figure 24. Global Carbamazepine API Revenue Market Share by Region (2017-2028)
Figure 25. North America Carbamazepine API Revenue (2017-2028) & (USD Million)
Figure 26. Europe Carbamazepine API Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Carbamazepine API Revenue (2017-2028) & (USD Million)
Figure 28. South America Carbamazepine API Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Carbamazepine API Revenue (2017-2028) & (USD Million)
Figure 30. Global Carbamazepine API Sales Market Share by Type (2017-2028)
Figure 31. Global Carbamazepine API Revenue Market Share by Type (2017-2028)
Figure 32. Global Carbamazepine API Price by Type (2017-2028) & (US$/Kg)
Figure 33. Global Carbamazepine API Sales Market Share by Application (2017-2028)
Figure 34. Global Carbamazepine API Revenue Market Share by Application (2017-2028)
Figure 35. Global Carbamazepine API Price by Application (2017-2028) & (US$/Kg)
Figure 36. North America Carbamazepine API Sales Market Share by Type (2017-2028)
Figure 37. North America Carbamazepine API Sales Market Share by Application (2017-2028)
Figure 38. North America Carbamazepine API Sales Market Share by Country (2017-2028)
Figure 39. North America Carbamazepine API Revenue Market Share by Country (2017-2028)
Figure 40. United States Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Carbamazepine API Sales Market Share by Type (2017-2028)
Figure 44. Europe Carbamazepine API Sales Market Share by Application (2017-2028)
Figure 45. Europe Carbamazepine API Sales Market Share by Country (2017-2028)
Figure 46. Europe Carbamazepine API Revenue Market Share by Country (2017-2028)
Figure 47. Germany Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Carbamazepine API Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Carbamazepine API Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Carbamazepine API Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Carbamazepine API Revenue Market Share by Region (2017-2028)
Figure 56. China Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Carbamazepine API Sales Market Share by Type (2017-2028)
Figure 63. South America Carbamazepine API Sales Market Share by Application (2017-2028)
Figure 64. South America Carbamazepine API Sales Market Share by Country (2017-2028)
Figure 65. South America Carbamazepine API Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Carbamazepine API Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Carbamazepine API Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Carbamazepine API Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Carbamazepine API Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Carbamazepine API Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Carbamazepine API in 2021
Figure 77. Manufacturing Process Analysis of Carbamazepine API
Figure 78. Carbamazepine API Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の医薬品用デキストラン市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用L-カルノシン市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用ホスファチジルセリン市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用フルクトース市場2022年：市場規模予測（～2028年）
  • 世界の医薬品用エチルセルロース（EC）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO2419 )"世界のカルバマゼピンAPI市場2022年：市場規模予測（～2028年）" (英文：Global Carbamazepine API Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。